Edward Imbrogno

2019

In 2019, Edward Imbrogno earned a total compensation of $814.1K as Vice President, Chief Financial Officer and Chief Accounting Officer at PDL BioPharma.

Compensation breakdown

Non-Equity Incentive Plan$211,943
Option Awards$167,500
Salary$294,200
Stock Awards$82,500
Other$58,000
Total$814,143

Imbrogno received $294.2K in salary, accounting for 36% of the total pay in 2019.

Imbrogno also received $211.9K in non-equity incentive plan, $167.5K in option awards, $82.5K in stock awards and $58K in other compensation.

Rankings

In 2019, Edward Imbrogno's compensation ranked 10,139th out of 13,971 executives tracked by ExecPay. In other words, Imbrogno earned more than 27.4% of executives.

ClassificationRankingPercentile
All
10,139
out of 13,971
27th
Division
Manufacturing
4,098
out of 5,701
28th
Major group
Chemicals And Allied Products
1,559
out of 2,200
29th
Industry group
Drugs
1,336
out of 1,886
29th
Industry
Biological Products, Except Diagnostic Substances
293
out of 389
25th
Source: SEC filing on July 7, 2020.

Imbrogno's colleagues

We found four more compensation records of executives who worked with Edward Imbrogno at PDL BioPharma in 2019.

2019

Dominique Monnet

PDL BioPharma

Chief Executive Officer

2019

Peter Garcia

PDL BioPharma

Chief Financial Officer

2019

Christopher Stone

PDL BioPharma

General Counsel

2019

Jill Jene

PDL BioPharma

Vice President, Business Development

News

You may also like